Submit Search
Upload
2016: Predicting Recurrence in Clear Cell Renal Cell Carcinoma
•
0 likes
•
91 views
University of Groningen
Follow
Talk presented at the WCCI in Vancouver/Canada, 2016
Read less
Read more
Science
Report
Share
Report
Share
1 of 16
Recommended
140127 rtg vcfeval vcf comparison tool
140127 rtg vcfeval vcf comparison tool
GenomeInABottle
ASHG 2017 Presentation
Towards Prediction of Platinum Treatment Response in Ovarian Cancer using Mac...
Towards Prediction of Platinum Treatment Response in Ovarian Cancer using Mac...
Antoaneta Vladimirova
This poster illustrates the steps taken for clinically validating and incorporating the Archer Fusionplex workflow into an existing clinical assay.
Validation of The Archer FusionPlex Solid Tumor Panel-AACR 2016
Validation of The Archer FusionPlex Solid Tumor Panel-AACR 2016
Samantha Helm
Jax GM Archer Fusionplex Solid Tumor Panel AMP Poster
Jax GM Archer Fusionplex Solid Tumor Panel AMP Poster
Samantha Helm
This workshop will address critical issues related to Transcriptomics data: Processing raw Next Generation Sequencing (NGS) data: 1. Next Generation Sequencing data preprocessing: Trimming technical sequences Removing PCR duplicates 2. RNA-seq based quantification of expression levels: Conventional pipelines (looking at known transcripts) Identification of novel isoforms Analysis of Expression Data Using Machine Learning: 3. Unsupervised analysis of expression data: Principal Component Analysis Clustering 4. Supervised analysis: Differential expression analysis Classification, gene signature construction 5. Gene set enrichment analysis The workshop will include hands-on exercises utilizing public domain datasets: breast cancer cell lines transcriptomic profiles (https://genomebiology.biomedcentral.com/articles/10.1186/gb-2013-14-10-r110), patient-derived xenograft (PDX) mouse model of tumor and stroma transcriptomic profiles (http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=8014&path[]=23533), and processed data from The Cancer Genome Atlas samples (https://cancergenome.nih.gov/). Team: The workshops are designed by the researchers at the Tauber Bioinformatics Research Center at University of Haifa, Israel in collaboration with academic centers across the US. Technical support for the workshops is provided by the Pine Biotech team. https://edu.t-bio.info/a-critical-approach-to-transcriptomic-data-analysis/
Mastering RNA-Seq (NGS Data Analysis) - A Critical Approach To Transcriptomic...
Mastering RNA-Seq (NGS Data Analysis) - A Critical Approach To Transcriptomic...
Elia Brodsky
We introduce PICS (Pathway Informed Classification System) for classifying cancers based on tumor sample gene expression levels. The method clearly separates a pan-cancer dataset into their tissue of origin and is also able to sub-classify individual cancer datasets into distinct survival classes. Gene expression values are collapsed into pathway scores that reveal which biological activities are most useful for clustering cancer cohorts into sub-types. Variants of the method allow it to be used on datasets that do and do not contain non-cancerous samples. Activity levels of all types of pathways, broadly grouped into metabolic, cellular processes and signaling, and immune system, are useful for separating the pan-cancer cohort. In the clustering of specific cancer types, certain pathway types become more valuable depending on the site being studied. For lung cancer, signaling pathways dominate, for pancreatic cancer signaling and metabolic pathways, and for melanoma immune system pathways are the most useful. This work suggests the utility of pathway level genomic analysis and points in the direction of using pathway classification for predicting the efficacy and side effects of drugs and radiation.
PICS: Pathway Informed Classification System for cancer analysis using gene e...
PICS: Pathway Informed Classification System for cancer analysis using gene e...
David Craft
International Conference on Applied Statistics (ICAS), Organized by ISRT, University of Dhaka.
Robust Prediction of Cancer Disease Using Pattern Classification of Microarra...
Robust Prediction of Cancer Disease Using Pattern Classification of Microarra...
Md Rahman
Economic evaluation seminar, Dr Peter Hall, Senior Lecturer, Edinburgh Cancer Research Centre
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
cheweb1
Recommended
140127 rtg vcfeval vcf comparison tool
140127 rtg vcfeval vcf comparison tool
GenomeInABottle
ASHG 2017 Presentation
Towards Prediction of Platinum Treatment Response in Ovarian Cancer using Mac...
Towards Prediction of Platinum Treatment Response in Ovarian Cancer using Mac...
Antoaneta Vladimirova
This poster illustrates the steps taken for clinically validating and incorporating the Archer Fusionplex workflow into an existing clinical assay.
Validation of The Archer FusionPlex Solid Tumor Panel-AACR 2016
Validation of The Archer FusionPlex Solid Tumor Panel-AACR 2016
Samantha Helm
Jax GM Archer Fusionplex Solid Tumor Panel AMP Poster
Jax GM Archer Fusionplex Solid Tumor Panel AMP Poster
Samantha Helm
This workshop will address critical issues related to Transcriptomics data: Processing raw Next Generation Sequencing (NGS) data: 1. Next Generation Sequencing data preprocessing: Trimming technical sequences Removing PCR duplicates 2. RNA-seq based quantification of expression levels: Conventional pipelines (looking at known transcripts) Identification of novel isoforms Analysis of Expression Data Using Machine Learning: 3. Unsupervised analysis of expression data: Principal Component Analysis Clustering 4. Supervised analysis: Differential expression analysis Classification, gene signature construction 5. Gene set enrichment analysis The workshop will include hands-on exercises utilizing public domain datasets: breast cancer cell lines transcriptomic profiles (https://genomebiology.biomedcentral.com/articles/10.1186/gb-2013-14-10-r110), patient-derived xenograft (PDX) mouse model of tumor and stroma transcriptomic profiles (http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=8014&path[]=23533), and processed data from The Cancer Genome Atlas samples (https://cancergenome.nih.gov/). Team: The workshops are designed by the researchers at the Tauber Bioinformatics Research Center at University of Haifa, Israel in collaboration with academic centers across the US. Technical support for the workshops is provided by the Pine Biotech team. https://edu.t-bio.info/a-critical-approach-to-transcriptomic-data-analysis/
Mastering RNA-Seq (NGS Data Analysis) - A Critical Approach To Transcriptomic...
Mastering RNA-Seq (NGS Data Analysis) - A Critical Approach To Transcriptomic...
Elia Brodsky
We introduce PICS (Pathway Informed Classification System) for classifying cancers based on tumor sample gene expression levels. The method clearly separates a pan-cancer dataset into their tissue of origin and is also able to sub-classify individual cancer datasets into distinct survival classes. Gene expression values are collapsed into pathway scores that reveal which biological activities are most useful for clustering cancer cohorts into sub-types. Variants of the method allow it to be used on datasets that do and do not contain non-cancerous samples. Activity levels of all types of pathways, broadly grouped into metabolic, cellular processes and signaling, and immune system, are useful for separating the pan-cancer cohort. In the clustering of specific cancer types, certain pathway types become more valuable depending on the site being studied. For lung cancer, signaling pathways dominate, for pancreatic cancer signaling and metabolic pathways, and for melanoma immune system pathways are the most useful. This work suggests the utility of pathway level genomic analysis and points in the direction of using pathway classification for predicting the efficacy and side effects of drugs and radiation.
PICS: Pathway Informed Classification System for cancer analysis using gene e...
PICS: Pathway Informed Classification System for cancer analysis using gene e...
David Craft
International Conference on Applied Statistics (ICAS), Organized by ISRT, University of Dhaka.
Robust Prediction of Cancer Disease Using Pattern Classification of Microarra...
Robust Prediction of Cancer Disease Using Pattern Classification of Microarra...
Md Rahman
Economic evaluation seminar, Dr Peter Hall, Senior Lecturer, Edinburgh Cancer Research Centre
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
cheweb1
coad_machine_learning
coad_machine_learning
Ford Sleeman
Liquid biopsies enable us to monitor the evolution of genetic aberrations in primary tumors as they shed the tumor cells into the circulation. The limitation is the ability to detect these low frequency genetic aberrations in a consistent manner to understand short- and long-term implications and how this information will be used in the clinic. This slidedeck will cover the challenges and solutions associated with multiple steps as one starts with liquid biopsy and move towards finding a new biomarker.
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
Step by Step, from Liquid Biopsy to a Genomic Biomarker: Liquid Biopsy Series...
QIAGEN
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
European School of Oncology
SANGER SEQUENCING - 1st generation sequencing Sanger Sequencing Workflow: PCR amplification (target enrichment) PCR purification (primer, dNTPs) Sequencing reaction (bi-directional) Sequencing purification (primer, dNTPs, ddNTPs) Electrophoretic run on sequencer Sequencing lecture Alignment to reference SANGER SEQUENCING: LIMITATIONS Analytical sensitivity*: 99% PCR-Based no detection deletion/duplication rearrangements del/dup BRCA = 4-28% of all BRCA mutations in most population** Level of mosaicism > 20% Low throughput (82496 capillary tubes) Labor intensive Time consuming High cost (large size gene or more genes)
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA